The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents
Sign Up to like & getrecommendations! Published in 2020 at "Critical Care"
DOI: 10.1186/s13054-020-02947-x
Abstract: We read with interest the recent meta-analysis by Chang et al. who investigated the role of neuromuscular blocking agent (NMBA) use in moderate-to-severe acute respiratory distress syndrome (ARDS) and discuss the potential mechanisms involved in… read more here.
Keywords: neuromuscular blocking; moderate ards; mortality; severe ards ... See more keywords